Researchers may have uncovered a side-effect in the macular degeneration treatment Lucentis. Lucentis is the leading treatment for wet macular degeneration. However, researchers at the Mayo … [Read more...]
Nova Scotia Contemplates Lucentis Treatment
December 31, 2009 By 1 Comment
Nova Scotia is contemplating providing coverage for Lucentis, the leading macular degeneration treatment. According to Maureen MacDonald, Nova Scotia's health minister, the province may pay for … [Read more...]
Lucentis Treatment for Wet Macular Degeneration – The UK and Canada
April 19, 2008 By Leave a Comment
The debate over Lucentis as a treatment for wet macular degeneration is continuing in both the United Kingdom and in Canada. Both Canada and the UK have publicly funded health care systems and with … [Read more...]
Lucentis Coverage in Ontario and Quebec, Canada
April 16, 2008 By 4 Comments
The macular degeneration drug Lucentis has coverage for funding in Ontario and Quebec, Canada. Shortly after the July 30, 2007 Notice of Compliance issued by Health Canada to Novartis Ophthalmics, … [Read more...]
Canada’s Drug Review Board Recommends Lucentis
March 28, 2008 By Leave a Comment
Lucentis, an anti-VEGF drug for treating wet macular degeneration has been recommended by Canada's drug review board the Common Drug Review Committee (CDR). This board recommends funding of the … [Read more...]
Recent Comments